Get the Stockscreener App
10.77
8.96%
-1.06
After Hours:
11.00
0.23
+2.14%
Exagen Inc stock is traded at $10.77, with a volume of 909.30K.
It is down -8.96% in the last 24 hours and down -1.73% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$11.83
Open:
$11.08
24h Volume:
909.30K
Relative Volume:
3.79
Market Cap:
$236.98M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-11.46
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-9.42%
1M Performance:
-1.73%
6M Performance:
+78.90%
1Y Performance:
+336.03%
1-Day Range:
$10.50
$11.50
1-Week Range:
$10.50
$11.92
52-Week Range:
$2.38
$12.23
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
10.77 | 260.30M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen Delivers Revenue Growth But Still Sees Losses - Finimize
Earnings call transcript: Exagen Q3 2025 reports record revenue, stock dips - Investing.com
Exagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
EXAGEN INC. SEC 10-Q Report - TradingView
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
XGN Forecasts Positive Adjusted EBITDA by Q4 2025 - GuruFocus
XGN Reports Q3 Revenue Surpassing Expectations - GuruFocus
Exagen Inc (XGN) Q3 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Exagen Inc. Reports Q3 2025 Financial Results with Record Revenue and Corporate Updates - Quiver Quantitative
Exagen Q3 revenue beats analyst expectations - MarketScreener
Exagen Inc. Reports Strong Q3 2025 Results - GlobeNewswire
How higher bond yields impact Exagen Inc. (E08A) stockRate Cut & High Conviction Buy Zone Alerts - newser.com
Visual trend scoring systems applied to Exagen Inc.July 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Is Exagen Inc. stock a top momentum playBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
Short interest data insights for Exagen Inc.2025 Earnings Impact & Expert Approved Momentum Trade Ideas - newser.com
Can trapped investors hope for a rebound in Exagen Inc.Weekly Trade Recap & Precise Buy Zone Identification - newser.com
Why Exagen Inc. (E08A) stock stays resilient2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Strategies to average down on Exagen Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Is Exagen Inc. stock poised for growth2025 Performance Recap & Technical Pattern Based Signals - newser.com
What To Expect From Exagen Inc (XGN) Q3 2025 Earnings - GuruFocus
Does Exagen Inc. stock trade at a discount to peers - newser.com
Is Exagen Inc. stock attractive for ETFsEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Is Exagen Inc. (E08A) stock good for wealth creationRate Hike & High Accuracy Buy Signal Tips - newser.com
Is Exagen Inc. stock a defensive play in 2025July 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Can Exagen Inc. stock sustain revenue growthJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
Candlestick signals on Exagen Inc. stock todayTrade Exit Summary & Weekly High Return Forecasts - newser.com
Why Exagen Inc. (E08A) stock stays on buy listsRate Cut & Technical Pattern Recognition Alerts - newser.com
Exagen Inc. stock retracement – recovery analysisTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
What to do if you’re stuck in Exagen Inc.Earnings Performance Report & Free Real-Time Market Sentiment Alerts - newser.com
Will Exagen Inc. benefit from macro trendsPortfolio Return Summary & Verified Swing Trading Watchlists - newser.com
What valuation ratios show for Exagen Inc. (E08A) stockGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Why Exagen Inc. (E08A) stock could be next leader2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
Will Exagen Inc. stock maintain momentum in 2025Weekly Investment Recap & Stock Timing and Entry Methods - newser.com
Will Exagen Inc. stock recover faster than peersGap Up & High Yield Stock Recommendations - newser.com
How to monitor Exagen Inc. with trend dashboards2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Exagen Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
6.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):